BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25652900)

  • 1. Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.
    Wang K; Pan D; Schmieder AH; Senpan A; Hourcade DE; Pham CT; Mitchell LM; Caruthers SD; Cui G; Wickline SA; Shen B; Lanza GM
    Nanomedicine; 2015 Apr; 11(3):601-9. PubMed ID: 25652900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits.
    Wang K; Pan D; Schmieder AH; Senpan A; Caruthers SD; Cui G; Allen JS; Zhang H; Shen B; Lanza GM
    Nanomedicine; 2015 Apr; 11(3):569-78. PubMed ID: 25652897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Gadolinium-Doped Manganese Carbonate Nanoparticles for Targeted MR/Fluorescence Imaging of Tiny Brain Gliomas.
    Shao C; Li S; Gu W; Gong N; Zhang J; Chen N; Shi X; Ye L
    Anal Chem; 2015 Jun; 87(12):6251-7. PubMed ID: 26008220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water-soluble MnO nanocolloid for a molecular T1 MR imaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities.
    Baek MJ; Park JY; Xu W; Kattel K; Kim HG; Lee EJ; Patel AK; Lee JJ; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
    ACS Appl Mater Interfaces; 2010 Oct; 2(10):2949-55. PubMed ID: 20929249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
    Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
    PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compact Micellization: A Strategy for Ultrahigh T1 Magnetic Resonance Contrast with Gadolinium-Based Nanocrystals.
    Johnson NJ; He S; Nguyen Huu VA; Almutairi A
    ACS Nano; 2016 Sep; 10(9):8299-307. PubMed ID: 27588579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
    Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
    Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of cyano-bridged coordination nanoparticles Gd(3+)/[Fe(CN)6](3-)/D-mannitol as T1-weighted MRI contrast agents.
    Perrier M; Gallud A; Ayadi A; Kennouche S; Porredon C; Gary-Bobo M; Larionova J; Goze-Bac Ch; Zanca M; Garcia M; Basile I; Long J; de Lapuente J; Borras M; Guari Y
    Nanoscale; 2015 Jul; 7(28):11899-903. PubMed ID: 25967733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing T
    Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging.
    de Vries A; Moonen R; Yildirim M; Langereis S; Lamerichs R; Pikkemaat JA; Baroni S; Terreno E; Nicolay K; Strijkers GJ; Grüll H
    Contrast Media Mol Imaging; 2014; 9(1):83-91. PubMed ID: 24470297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
    Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
    Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
    Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
    ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration.
    Ghaghada K; Hawley C; Kawaji K; Annapragada A; Mukundan S
    Acad Radiol; 2008 Oct; 15(10):1259-63. PubMed ID: 18790397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Gd(III) porphyrin-conjugated chitosan nanoparticles as contrast agents for magnetic resonance imaging.
    Jahanbin T; Sauriat-Dorizon H; Spearman P; Benderbous S; Korri-Youssoufi H
    Mater Sci Eng C Mater Biol Appl; 2015; 52():325-32. PubMed ID: 25953574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.